Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 91

Results For "medicine"

1883 News Found

Ayush Ministry signs MoU with Department of ex-servicemen welfare
Policy | March 27, 2023

Ayush Ministry signs MoU with Department of ex-servicemen welfare

Ayurveda OPD will be established in 10 ECHS Polyclinic/Dispensaries in various regions of India to cover all ECHS members on a voluntary basis


Pfizer acquisition of ADC trailblazer Seagen a worthy investment: GlobalData
News | March 25, 2023

Pfizer acquisition of ADC trailblazer Seagen a worthy investment: GlobalData

Pfizer’s total cumulative revenue from Seagen therapies is expected to reach $36 billion by 2028, according to GlobalData, a leading data and analytics company.


hubergroup India expands its support for rural healthcare
Healthcare | March 24, 2023

hubergroup India expands its support for rural healthcare

hubergroup’s two newly added medical vans are dedicated to dental and eye care


Investment in healthcare workforce key to accelerating India’s economic growth: Experts
Healthcare | March 23, 2023

Investment in healthcare workforce key to accelerating India’s economic growth: Experts

Integration of modern and traditional medicine to facilitate the illness to wellness journey


OPPI launches ‘Bharat Ke Liye’ to reinforce commitment to improve health outcomes
Healthcare | March 23, 2023

OPPI launches ‘Bharat Ke Liye’ to reinforce commitment to improve health outcomes

This initiative encapsulates the essence of OPPI’s commitment towards enabling a healthier India


Osteoarthritis candidate MM-II showed durable pain relief in Global Phase 2b study
Diagnostic Center | March 23, 2023

Osteoarthritis candidate MM-II showed durable pain relief in Global Phase 2b study

The data from this study show that MM-II has the potential to provide durable pain relief for our patients


Zydus granted Orphan Drug Designation by USFDA for ZYIL1
Drug Approval | March 22, 2023

Zydus granted Orphan Drug Designation by USFDA for ZYIL1

ZYIL1 is a novel oral small molecule NLRP3 inhibitor which has demonstrated CSF penetration in non-human primates


Phase 3 data show Deuruxolitinib significantly improve scalp hair regrowth in Alopecia Areata
News | March 20, 2023

Phase 3 data show Deuruxolitinib significantly improve scalp hair regrowth in Alopecia Areata

The Phase 3 data presented at AAD include a comprehensive review of the THRIVE-AA2 results and further elaborate the topline data reported in August 2022


Drug coated balloons is an alternative to stents in younger patients: Experts
News | March 18, 2023

Drug coated balloons is an alternative to stents in younger patients: Experts

This is especially the case if the patients are young, have multiple blocks & have conditions that may make angioplasty to implant drug-eluting stents ineffective


Jubilant receives additional CAD 23.8 million loan facility for CMO Montreal facility
News | March 17, 2023

Jubilant receives additional CAD 23.8 million loan facility for CMO Montreal facility

This loan is in addition to earlier announced CAD 25 million loan committed by the Province of Quebec